Purinergic signaling through the P2Y2 receptor regulates osteocytes’ mechanosensitivity
Osteocytes' response to dynamic loading plays a crucial role in regulating the bone mass but quickly becomes saturated such that downstream induction of bone formation plateaus. The underlying mechanisms that downregulate osteocytes' sensitivity and overall response to loading remain unknown. In other cell types, purinergic signaling through the P2Y2 receptor has the potential to downregulate the sensitivity to loading by modifying cell stiffness through actin polymerization and cytoskeleton organization. Herein, we examined the role of P2Y2 activation in regulating osteocytes' mechanotransduction using a P2Y2 knockout cell line alongside conditional knockout mice. Our findings demonstrate that the absence of P2Y2 expression in MLO-Y4 cells prevents actin polymerization while increasing the sensitivity to fluid flow-induced shear stress. Deleting osteocytes' P2Y2 expression in conditional-knockout mice enabled bone formation to increase when increasing the duration of exercise. Overall, P2Y2 activation under loading produces a negative feedback loop, limiting osteocytes' response to continuous loading by shifting the sensitivity to mechanical strain through actin stress fiber formation.
Authors
- Amit Chougule (ORCID: https://orcid.org/0000-0003-2981-3745)
- Chenjun Shi (ORCID: https://orcid.org/0000-0002-9581-7974)
- Devin Mendez
- Joseph D. Gardinier (ORCID: https://orcid.org/0000-0002-8651-8913)
- Jitao Zhang (ORCID: https://orcid.org/0000-0002-6240-0371)
- Elizabeth Vojtisek
- Nickolas Vinokurov
- Chunbin Zhang
Institutions
- Henry Ford Health System (US)
- Wayne State University (US)
- Henry Ford Health + Michigan State University Health Sciences (US)
- Michigan State University (US)
Publication Details
- Journal
- The Journal of Cell Biology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1083/jcb.202403005
- Citations
- 5
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- National Science Foundation
- Massachusetts General Hospital
- University of Missouri
- National Institutes of Health
- Division of Chemical, Bioengineering, Environmental, and Transport Systems